From condition to compound — evidence at every step
SkaiPharma connects disease indications to drugs, FDA labels, clinical trials, and competitive intelligence — all graded by evidence and traceable to source.
Core Capabilities
Five pillars of pharmaceutical intelligence
Indication Intelligence
57+ indications · approval status · drug count per condition
Start from a disease — see every drug approved or investigational for that condition, with mechanism, evidence grade, and trial status. Epidemiology data and ICD-10/SNOMED coding included.
Drug Intelligence
141 drugs · 106 approved · 9 FDA label sections
Full drug profiles: mechanism, targets, patents, PK, adverse effects, indication status, headlines, financials. FDA labels downloaded and structured from openFDA.
Evidence Engine
2,071+ claims · 10 evidence grades · contradiction detection
Every claim is traceable to its source: FDA label, Phase 3 RCT, SEC filing, peer review, or preprint. Inspect confidence scores. See where evidence conflicts.
Trial & Commercial Signals
717+ trials · 30+ companies · 3 CI scores
Daily trial sync from ClinicalTrials.gov. Quarterly financials from SEC EDGAR. Target crowding, trial momentum, and evidence strength scores — all decomposable.
AI Analysis & Workspaces
13 AI tools · team workspaces · REST API
Claude-powered insights with structured efficacy extraction from FDA labels. Private team overlays, saved briefings, and a ChatGPT-compatible API.
Platform Tour
From condition to insight in six steps
Search a Condition
Start by searching a disease — psoriasis, Alzheimer's, heart failure, or any of 57+ covered indications. The platform surfaces all relevant drugs, trials, and evidence immediately.
57+ indications · across 6 therapeutic areas
Try the search →Explore Drugs for That Indication
See every approved and investigational drug mapped to the indication — with mechanism of action, approval status, and trial phase. Sorted by evidence strength.
141 drugs · 106 approved · real-time approval status
Example: plaque psoriasis →Drill Into a Drug Profile
Click any drug to see its full profile: mechanism summary, molecular targets, FDA label sections, clinical trial results, patent portfolio, PK parameters, and adverse effects.
141 drugs · 9 FDA label sections · Generate AI Brief button
Browse drugs →Inspect the Evidence
Every claim shows its evidence grade (LABEL_REGULATORY to NEWS_SECONDARY), confidence score, source URL, and extraction method. No black boxes. See where claims conflict.
2,071+ claims · 10 evidence grades · contradiction detection
Compare Efficacy Across Drugs
Ask the AI assistant to compare drugs within an indication. Get structured tables from FDA label data: primary endpoints, response rates, p-values, enrollment — all pre-extracted.
13 AI tools · PASI 75/90/100 comparisons · NCT-cited sources
Save, Brief & Collaborate
Generate analyst-grade briefings with one click. Save to your workspace. Add private notes and watchlists. Export as Markdown or JSON. Query the API programmatically.
Team workspaces · Markdown/JSON export · 8 API endpoints
See PRO features →Why SkaiPharma
What makes this different from Citeline, Cortellis, or Evaluate
Indication-first, not mechanism-catalog-first
Start from a disease condition, not a pathway diagram. Understand which drugs treat it and with what evidence before drilling into mechanisms.
Evidence-inspectable, not black-box summarized
Every claim has a grade, a source, and a confidence score. When evidence conflicts, we show the disagreement — not a flattened average.
Structured efficacy from FDA labels, not just linked PDFs
We download, parse, and structure the Clinical Studies section of every FDA label. Primary endpoints, response rates, and p-values are queryable, not buried in 50-page documents.
Commercial + biological + regulatory + temporal in one view
Company financials, mechanism biology, regulatory status, and trial momentum in one platform. No tab-switching between 4 different tools.
Architecture
What lives under the hood
13 automated pipelines
FDA labels, ClinicalTrials.gov, SEC filings, headlines from 6 sources, patent data, stock prices — all on daily/weekly/quarterly crons
10 evidence grades
LABEL_REGULATORY, PHASE_3_RCT, PHASE_2_RCT, OBSERVATIONAL_HUMAN, PRECLINICAL, COMPANY_DISCLOSURE, PEER_REVIEW, PREPRINT, NEWS_SECONDARY, EXPERT_CURATION
13 AI tools
query_drugs, query_trials, query_financials, query_label, query_efficacy, query_evidence, query_scores, query_graph, query_changes, fetch_clinicaltrials_gov, generate_table, generate_chart, generate_brief
8 public API endpoints
Drugs, trials, indications, companies, scores, evidence — with OpenAPI 3.1.0 spec, compatible with ChatGPT Custom GPTs
Private workspaces
Team annotations, watchlists, saved briefings — private overlays that never leak into public content or AI outputs
Use Cases
Built for people who need answers, not dashboards
Pharma Strategy Lead
“Where is the next open space for our portfolio?”
Map mechanisms, see unaddressed pathways, and compare competitive intensity by target and indication.
Clinical Development Analyst
“Which mechanisms have the strongest clinical evidence for our target indication?”
Surface all drugs, trials, and FDA label efficacy data linked to mechanistic nodes — with evidence grading.
Business Intelligence Lead
“What are competitors pursuing that we aren't?”
Track company portfolios, trial activity, and commercial signals by mechanism or indication. Decomposable CI scores.
Medical Science Liaison
“Can I trust this claim about a drug's effect?”
Drill down to the original evidence. Every claim is source-linked, graded for reliability, and shows contradiction status.
See It In Action
Three minutes from question to insight
Demo video coming soon
Prefer a live walkthrough? Request one →
Ready to see what you're missing?
Explore the atlas now or request a live walkthrough. We onboard teams weekly.
Ad-free. Independent. Evidence-grounded.